JP7784431B2 - 新規化合物 - Google Patents

新規化合物

Info

Publication number
JP7784431B2
JP7784431B2 JP2023537724A JP2023537724A JP7784431B2 JP 7784431 B2 JP7784431 B2 JP 7784431B2 JP 2023537724 A JP2023537724 A JP 2023537724A JP 2023537724 A JP2023537724 A JP 2023537724A JP 7784431 B2 JP7784431 B2 JP 7784431B2
Authority
JP
Japan
Prior art keywords
indazol
acrylamide
methyl
alkyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023537724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539695A (ja
JP2023539695A5 (cg-RX-API-DMAC7.html
Inventor
ミラー ニール
ラター リチャード
ラドゥワヘッティ タミー
マクリーン ジョン
タルボット エリック
クラゴウスキ ジャン
モーフィー リチャード
Original Assignee
エヌアールジー セラピューティクス エルティーディー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エヌアールジー セラピューティクス エルティーディー filed Critical エヌアールジー セラピューティクス エルティーディー
Publication of JP2023539695A publication Critical patent/JP2023539695A/ja
Publication of JP2023539695A5 publication Critical patent/JP2023539695A5/ja
Application granted granted Critical
Publication of JP7784431B2 publication Critical patent/JP7784431B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2023537724A 2020-09-01 2021-09-01 新規化合物 Active JP7784431B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2013731.1A GB202013731D0 (en) 2020-09-01 2020-09-01 Novel cmpounds
GB2013731.1 2020-09-01
PCT/GB2021/052262 WO2022049377A1 (en) 2020-09-01 2021-09-01 Novel compounds

Publications (3)

Publication Number Publication Date
JP2023539695A JP2023539695A (ja) 2023-09-15
JP2023539695A5 JP2023539695A5 (cg-RX-API-DMAC7.html) 2024-09-11
JP7784431B2 true JP7784431B2 (ja) 2025-12-11

Family

ID=72749727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023537724A Active JP7784431B2 (ja) 2020-09-01 2021-09-01 新規化合物

Country Status (9)

Country Link
US (1) US12497359B2 (cg-RX-API-DMAC7.html)
EP (1) EP4208448B1 (cg-RX-API-DMAC7.html)
JP (1) JP7784431B2 (cg-RX-API-DMAC7.html)
CN (1) CN116096712B (cg-RX-API-DMAC7.html)
AU (1) AU2021336750A1 (cg-RX-API-DMAC7.html)
CA (1) CA3190786A1 (cg-RX-API-DMAC7.html)
GB (1) GB202013731D0 (cg-RX-API-DMAC7.html)
IL (1) IL300904A (cg-RX-API-DMAC7.html)
WO (1) WO2022049377A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202013728D0 (en) 2020-09-01 2020-10-14 Nrg Therapeutics Ltd Novel compounds
GB202300833D0 (en) 2023-01-19 2023-03-08 Nrg Therapeutics Ltd Novel compounds
CN121866248A (zh) 2023-09-05 2026-04-14 Nrg治疗有限公司 作为mptp抑制剂起作用的吡啶衍生物
CN118255724A (zh) * 2024-03-27 2024-06-28 河北天成药业股份有限公司 盐酸利多卡因杂质的合成方法及其反应检测方法
GB202410534D0 (en) 2024-07-18 2024-09-04 Nrg Therapeutics Ltd Novel method and uses
CN120025281A (zh) * 2025-04-22 2025-05-23 九洲药业(杭州)有限公司 一种n,n-二异丁基-1h-吲唑-4-胺的中间体及制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012506852A (ja) 2008-10-27 2012-03-22 コンジェニア・エッセエッレエッレ ミトコンドリアの膜透過性遷移の阻害剤として有用なアクリルアミド誘導体
JP2023539694A (ja) 2020-09-01 2023-09-15 エヌアールジー セラピューティクス エルティーディー 新規化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003020313A1 (ja) 2001-09-04 2004-12-16 小野薬品工業株式会社 スフィンゴシン−1−リン酸受容体調節剤からなる呼吸器疾患治療剤
AU2002354476A1 (en) 2001-12-14 2003-06-30 Japan Tobacco Inc. Pyrazolopyridine derivatives and medicinal use thereof
JP2006512306A (ja) 2002-08-29 2006-04-13 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション アリール及びヘテロアリールプロペンアミド、それらの誘導体並びにそれらの治療用途
BRPI0619263A2 (pt) * 2005-11-30 2011-09-27 Hoffmann La Roche indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
JP5495206B2 (ja) 2006-10-24 2014-05-21 コンジエニア・ソシエタ・ア・レスポンサビリタ・リミタータ 変性性組織障害をmptの阻害により防止するための薬剤としてのフェニル置換マレイミド
WO2011087051A1 (ja) 2010-01-14 2011-07-21 国立大学法人金沢大学 S1p2受容体アンタゴニストを含む粥状動脈硬化治療薬
JP2017538676A (ja) 2014-11-05 2017-12-28 ザ ユニバーシティ オブ カンザス ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤
CA2884607A1 (en) 2015-03-11 2016-09-11 Stealth Peptides International, Inc. Therapeutic compositions including acrylamido compounds or phenyl-substiituted maleimide compounds and uses thereof to treat and prevent mitochondrial diseases and conditions
WO2019002624A1 (de) 2017-06-30 2019-01-03 Kleuser, Burkhard Mittel zur therapie entzündlicher darmerkrankungen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012506852A (ja) 2008-10-27 2012-03-22 コンジェニア・エッセエッレエッレ ミトコンドリアの膜透過性遷移の阻害剤として有用なアクリルアミド誘導体
JP2023539694A (ja) 2020-09-01 2023-09-15 エヌアールジー セラピューティクス エルティーディー 新規化合物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Chen Mao Xiang et al.,Probing Mitochondrial Permeability Transition Pore Actvity in Nucleated Cells and Platelets by High-Throughput Screening Assays Suggests Involvement of Protein Phosphatase 2B in Mitochondrial Dynamics,Assay and DrugDevelopment Technologies,2018年,16(8),445-455
REGISTRY (STN) [online],2009.01.23 [検索日 2025.05.08] CAS登録番号 1159511-66-6
REGISTRY (STN) [online],2014.03.06 [検索日 2025.05.08] CAS登録番号 1563253-76-8

Also Published As

Publication number Publication date
CN116096712B (zh) 2026-03-17
JP2023539695A (ja) 2023-09-15
EP4208448A1 (en) 2023-07-12
CN116096712A (zh) 2023-05-09
IL300904A (en) 2023-04-01
GB202013731D0 (en) 2020-10-14
EP4208448B1 (en) 2025-04-23
AU2021336750A1 (en) 2023-03-02
US12497359B2 (en) 2025-12-16
US20230312466A1 (en) 2023-10-05
CA3190786A1 (en) 2022-03-10
WO2022049377A1 (en) 2022-03-10

Similar Documents

Publication Publication Date Title
US20230159501A1 (en) Bipyrazole derivatives as jak inhibitors
CN116096712B (zh) 新型化合物
JP7784430B2 (ja) 新規化合物
HK1245769A1 (en) Bipyrazole salt as jak inhibitor
JP2025508898A (ja) アクリルアミド化合物
JP2026503519A (ja) mPTPの阻害剤
HK40103736A (en) Bipyrazole derivatives as jak inhibitors
HK40131992A (en) Bipyrazole derivatives as jak inhibitors
HK40103736B (en) Bipyrazole derivatives as jak inhibitors
HK40049209B (en) Bipyrazole derivatives as jak inhibitors
HK40012259A (en) Bipyrazole derivatives as jak inhibitors
HK40049209A (en) Bipyrazole derivatives as jak inhibitors
HK40012259B (en) Bipyrazole derivatives as jak inhibitors
HK1221466B (en) Bipyrazole derivatives as jak inhibitors
NZ753636B2 (en) Bipyrazole derivatives as jak inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240829

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240829

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250612

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250708

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251007

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251111

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251201

R150 Certificate of patent or registration of utility model

Ref document number: 7784431

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150